Medicinal Mushrooms & Mental Health

The CNP Medicinal Mushrooms & Mental Health Research Category consolidates research exploring the interconnected relationship between medicinal mushrooms and mental health. Cassidy Axelrod is CNP's Medicinal Mushrooms and Mental Health contributor and is the lead developer of this research category. To view each original study on the open internet, click “Original.” To view the CNP-written abstract summary, click “CNP Summary.” While only some of the CNP-written abstract summaries are available below for free, all abstract summaries are available to CNP members through the CNP Library Membership.

2020

Prevention of early Alzheimer’s disease by Erinacine A-Enriched Hericium erinaceus Mycelia pilot double-blind placebo-controlled study

2020

Online survey for patient outcomes on Hericium erinaceous mushroom

2016

Evaluation of antianxiety potential of four ganoderma (Agaricomycetes) species from India in mice

2021

Medicinal mushrooms: Bioactive compounds, use, and clinical trials

2019

Improvement of cognitive functions by oral intake of Hericium erinaceus

2019

Antidepressant effect of tetragonia tetragonoides (pall.) kuntzeextract on serotonin turnover

Logo

CNP Research Summary can be found in the CNP Library Membership

2021

Identification of the antidepressant function of the edible mushroom pleurotus eryngii

2020

Ganoderma lucidumameliorates neurobehavioral changes and oxidative stress induced by ethanol binge drinking

2016

Griflola frondosa (GF) produces significant antidepressant effects involving AMPA receptor activation in mice